Tel: 1-631-624-4882
Email: info@creative-peptides.com

What is the Semax Peptide?

Online Inquiry

The synthetic heptapeptide Semax derives from ACTH which functions as a natural hormone that controls adrenal gland activity and cortisol release. Scientists synthesized Semax to create a neuroprotective and cognitive-enhancing compound designed to function as both an essential treatment and preventative measure for numerous neurological disorders. The peptide Semax consists of the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro. Scientists engineered this peptide to replicate a portion of ACTH yet removed its hormonal functions to achieve neuroprotection and cognitive enhancement (CE) objectives. Semax now stands recognized for its dual role in enhancing brain functions like memory and attention while acting as a protective agent for patients suffering from stroke and traumatic brain injuries. Russia has authorized Semax for treatment of ischemic brain strokes and use in treating encephalopathy plus optic nerve atrophy and dementia-related cognitive disorders. The therapeutic potential of Semax for Alzheimer's disease (AD) treatment and ADHD management is under scientific investigation along with its effects on depression treatment and neuropsychological disorder management. The peptide Semax targets neurotransmitter systems alongside brain neurotrophic factors including brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) which support neuronal survival and synaptic plasticity as well as cognitive functionality.

Mechanism of Action of Semax Peptide

(1) Neurotransmitter Regulation

Through its impact on dopamine and serotonin concentrations Semax peptide regulates both mood stability and cognitive functions alongside attention processes. Mental clarity and anxiety reduction occur through Semax peptide's modulation of neurotransmitter systems which also leads to enhanced cognitive performance. Higher dopamine levels strengthen motivation and improve attention span duration together with increased serotonin levels which maintain mood stability while decreasing stress levels. Semax serves as a powerful enhancer of cognitive functions and emotional states through its dual impact on neurotransmitter systems.

(2) BDNF Enhancement

When Semax is administered it produces a notable elevation in brain-derived neurotrophic factor (BDNF) which plays a vital role in neuron development and maintenance. BDNF functions as an essential element in neuroplasticity which promotes brain adaptation through the creation of new neural connections. Semax initiates new neuron formation by increasing BDNF expression mainly in the hippocampus which holds a crucial position in learning and memory functions. Higher levels of BDNF boost memory retention and recall capabilities and improve the brain's protection against neurodegenerative disorders.

(3) Neuroprotection

Semax functions as an effective neuroprotectant by decreasing oxidative damage and brain inflammation. This chemical eliminates harmful free radicals which damage neurons and lead to neurodegenerative diseases through its antioxidant function. Semax moderates immune responses within the central nervous system and lowers pro-inflammatory cytokine production to reduce neuroinflammation. Semenax protects neurons from damage by using its antioxidant and anti-inflammatory properties which simultaneously preserves brain health to fight against neural degeneration.

(4) Improved Blood Flow

Semenax enhances cerebral circulation which delivers essential oxygen and nutrients to brain cells that support peak mental performance. Enhanced blood circulation allows the brain to expel metabolic waste products more efficiently enhancing brain health. Semax peptide strengthens vascular health to shield against ischemic injury and promote stroke recovery. The fundamental action of Semax is the promotion of blood flow to the brain which establishes the basis for both its protective nervous system functions and its cognitive performance improvements.

What is the Semax Peptide used for?

(1) Medical Applications

Semax peptide stands out as a promising therapeutic agent in the medical field for neurological treatment options. Healthcare providers use Semax peptide mainly for stroke and traumatic brain injury (TBI) treatment. The clinical trial findings suggest Semax promotes recovery through neurogenesis support and increased neuron functionality which leads to decreased cognitive losses and motor impairments in stroke and TBI patients. Research demonstrates that stroke patients who receive Semax treatment achieve better motor function and increased independence. Researchers today are investigating whether Semax therapy offers therapeutic advantages for neurodegenerative disorders such as Alzheimer's disease. Early AD patients experience improved memory and learning capabilities through enhanced BDNF levels and neuroplasticity using this treatment which also delays cognitive deterioration. The Russian medical authorities have approved Semax for treating various neurological conditions like ischemic brain stroke and dementia-related cognitive disorders.

(2) Cognitive Enhancement (CE)

Semax has become popular with those seeking mental performance improvement because of its recognized CE benefits. Research indicates that Semax use leads to marked improvements in both memory retention and concentration capacities among healthy individuals. Semax enhances brain functions by stimulating neuroplasticity and adjusting neurotransmitter levels which aids in both information processing and memory retention. Daily Semax treatment leads to improved problem-solving abilities and higher levels of productivity.

(3) Mood Regulation

Research demonstrates that Semax has powerful mood-regulating effects which reduce anxiety and stress levels. Through its effects on serotonin and dopamine neurotransmitters Semax provides enhanced mood stability and reduced anxiety symptoms. Studies show that Semax triggers neurotransmitter release which leads to better emotional balance and increased positivity. Recent research has revealed that Semax exhibits properties that may serve as both an antidepressant and an anxiolytic agent. Animal studies show that Semax acts as an antidepressant in stressful environments which makes it a promising candidate for mood disorder treatment expansion. Through its ability to induce a mental state that combines a serene focus Semax supports stress management and emotional stability.

(4) Physical Performance

Semax boosts athletic performance while providing benefits for cognitive function and brain health. This method provides benefits for stamina enhancement and recovery improvement so sports and bodybuilding professionals employ it. Semax extends exercise duration capabilities and speeds up recovery after workouts by enhancing brain blood circulation and minimizing oxidative damage. Semax's neuroprotective properties improve physical performance by diminishing mental exhaustion that occurs during long exercise periods. Through its ability to modulate neurotransmitters and improve neuroplasticity Semax helps athletes reach peak performance levels while providing enhanced mental focus and clarity. Semax reduces muscle soreness through its anti-inflammatory properties which also enhance post-exercise recovery speed.

Comparison: Semax vs. Selank

Mechanisms: The synthetic peptides Semax and Selank use different mechanisms to affect multiple aspects of brain wellness and mental capabilities. Semax emerges from ACTH fragments to improve cognitive abilities by adjusting neurotrophins and neuropeptides in the brain. When Semax initiates BDNF release it supports neuroplasticity by aiding the formation of new neural pathways. This peptide modulates dopamine and serotonin neurotransmitter levels which support brain functions related to motivation maintenance and mood stability as well as focus enhancement.

Selank develops from the peptide tuftsin and exerts its effects through GABAergic and serotonergic systems to reduce anxiety while sustaining positive emotions. Selank controls the expression of essential neuropeptides and neurotransmitters such as serotonin and dopamine which support mental resilience enhancement while decreasing stress levels. The anxiolytic effects of Selank stem from its enhancement of GABA activity which produces a more tranquil mental state and improved emotional regulation.

Applications: The separate mechanisms through which Semax and Selank operate enable them to address diverse therapeutic requirements and cognitive improvement goals. Semax distinguishes itself through its comprehensive CE abilities that simultaneously improve memory function and enhance focus and learning ability. Personal cognitive development seekers benefit from this treatment which medical professionals administer to patients who have suffered strokes or brain injuries and who live with Alzheimer's disease. Semax functions as a vital tool for cognitive preservation throughout life by enabling neuroplasticity and neuroprotection while also supporting brain recovery from injuries.

Selank functions primarily as a substance that acts to reduce anxiety and stabilize mood. The exceptional ability of this substance to reduce anxiety and stress levels accounts for its extensive use among individuals dealing with severe anxiety or stress disorders. Selank boosts mental performance during stressful situations through its regulation of serotonin and dopamine neurotransmitters. The primary function of Selank is to work as an anxiolytic and mood stabilizer while simultaneously providing CE.

N-Acetyl Semax vs. Semax

Chemical Modifications: The N-Acetyl Semax peptide represents a modified form of Semax where an acetyl group has been attached to the N-terminal end of the peptide chain. The chemical modification greatly improves both stability and bioavailability of the peptide. The acetyl group shields the peptide against fast enzymatic breakdown which enables prolonged activity inside the body. The compound achieves greater brain penetration due to its improved stability which enhances its therapeutic effectiveness. The peptide's solubility and absorption rates improve after they add the acetyl group. The quick absorption of N-Acetyl Semax by bodily tissues during administration permits greater quantities of the active compound to access both the bloodstream and the brain. Achieving necessary therapeutic concentrations for CE and neuroprotective applications depends on the peptide's improved bioavailability.

Enhanced Efficacy: N-Acetyl Semax shows superior effectiveness compared to standard Semax due to its enhanced stability and bioavailability. Protecting the peptide from fast breakdown and boosting brain absorption of the active compound occurs when an acetyl group is added to its structure. Users experience stronger and more enduring effects when taking N-Acetyl Semax than when using standard Semax. The extended period of activity demonstrates significant benefits for N-Acetyl Semax. The peptide's ability to withstand enzymatic degradation enables it to preserve its body activity over an extended period. The peptide delivers extended CE and brain protection effects to users. N-Acetyl Semax users who seek memory or concentration enhancement benefit from extended effects that help maintain daily performance. N-Acetyl Semax achieves better absorption and utilization by the body because of its enhanced bioavailability. N-Acetyl Semax emerges as the superior choice for those seeking top CE because of its enhanced performance. N-Acetyl Semax generates more pronounced mental performance improvements for many users compared to standard Semax. Individuals engaged in complicated mental tasks along with patients recovering from brain injuries experience significant improvements from this enhanced capability.

Current Research and Future Directions

Ongoing Studies: Research is ongoing to determine how Semax can serve as a treatment option for multiple cognitive and psychiatric conditions. New clinical trials demonstrate positive outcomes when Semax is used as supplemental treatment for Attention Deficit Hyperactivity Disorder (ADHD). Scientific studies show that Semax boosts both attention and concentration which are essential for managing ADHD symptoms. Semanax improves task concentration by reducing distractions via modulation of dopamine and serotonin neurotransmitter levels. Research reveals that Semax provides emotional regulation benefits which support improved control of impulsive behaviors along with stabilized mood patterns among ADHD patients. Randomized studies confirmed that Semax treatment resulted in major depressive disorder patients obtaining significant symptom reduction and functional benefits. The antidepressant effects of Semax could be due to its dual function of neurotransmitter regulation and enhancement of neuroplasticity. Research trials with generalized anxiety disorder patients indicated that Semax administration led to both decreased anxiety symptoms and enhanced quality of life. Research results indicate Semax represents a beneficial treatment option for mood and anxiety disorders.

Optimizing Delivery Methods: The development of effective delivery methods is essential to fully harness Semax's therapeutic potential. The nasal spray formulation stands out as one of the most examined and frequently used delivery methods. Nasal administration provides multiple benefits through swift mucosal absorption and direct brain access via the olfactory bulb which allows it to circumvent the blood-brain barrier. The chosen delivery approach provides faster drug action initiation and improved bioavailability which makes it especially appropriate for CE therapies and neuroprotective treatments. Current research efforts concentrate on enhancing the nasal spray formulation to boost its therapeutic performance. Studies show that including precise excipients or employing particular delivery systems improves both stability and absorption of Semax inside the nasal cavity. By incorporating nanoparticles or liposomes into the formulation the peptide benefits from protection against degradation and improved transport through the nasal mucosa. The development of these technologies enables sustained and steady delivery of the active compound which boosts its therapeutic benefits.

Semax Peptides at Creative Peptides

CAT#Product NameM.WMolecular FormulaPrice
HB00114Semax813.9C37H51N9O10SInquiry
R2209Semax acetate(free base)874C39H55N9O12SInquiry
10-101-257N-acetyl semax813.920C37H51N9O10SInquiry
10-101-313N-acetyl semax amidate813.92C39H54N10O10SInquiry
R1830ACTH (4-10)962.1C44H59N13O10SInquiry

References

  1. Sciacca, M.F.M.; Naletova, I.; Giuffrida, M.L. Semax, a synthetic regulatory peptide, affects copper-induced abeta aggregation and amyloid formation in artificial membrane models. ACS Chemical Neuroscience. 2022, 13(4): 486-496. https://doi.org/10.1021/acschemneuro.1c00707.
  2. Sudarkina, O.Y.; Filippenkov, I.B.; Stavchansky, V.V.; Denisova, A.E.; Yuzhakov, V.V.; Sevan'kaeva, L.E.; Valieva, L.V.; Remizova, J.A.; Dmitrieva, V.G.; Gubsky, L.V.; et al. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion. Int. J. Mol. Sci. 2021, 22, 6179. https://doi.org/10.3390/ijms22126179.
  3. Filippenkov, I.B.; Stavchansky, V.V.; Denisova, A.E.; Yuzhakov, V.V.; Sevan'kaeva, L.E.; Sudarkina, O.Y.; Dmitrieva, V.G.; Gubsky, L.V.; Myasoedov, N.F.; Limborska, S.A.; et al. Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in Rats. Genes. 2020, 11, 681. https://doi.org/10.3390/genes11060681.
  4. Volkova, A.; Shadrina, M.; Kolomin, T.; Andreeva, L.; Limborska, S.; Myasoedov, N.; Slominsky, P. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. Front. Pharmacol. 2016, 7:31. https://doi.org/10.3389/fphar.2016.00031.
Quick Inquiry
×
Get in touch with us

USA

Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA

Tel: 1-631-624-4882

Fax: 1-631-614-7828

Email: info@creative-peptides.com

 

Germany

Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main

Email: info@creative-peptides.com

Copyright © 2025 Creative Peptides. All rights reserved.